日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Shigella OspF blocks rapid p38-dependent priming of the NAIP-NLRC4 inflammasome

志贺氏菌OspF阻断p38依赖的NAIP-NLRC4炎症小体的快速启动

Turcotte, Elizabeth A; Kim, Kyungsub; Eislmayr, Kevin D; Goers, Lisa; Mitchell, Patrick S; Lesser, Cammie F; Vance, Russell E

Differential targeting of human pyroptotic caspase-5 and caspase-4 by Shigella OspC2 and OspC3

志贺氏菌OspC2和OspC3对人焦亡caspase-5和caspase-4的差异性靶向作用

Kim, Kyungsub; Valdespino Diaz, Marcos Antonio; Karr, Rowan M; Muscolo, Michele E; Goers, Lisa; Yu, Truelian; Levin, Tera C; Pruneda, Jonathan N; Lesser, Cammie F

The bacterial type three secretion system induces mechanoporation of vacuolar membranes.

细菌的 III 型分泌系统可诱导液泡膜的机械穿孔

Swistak Léa, Albert Marvin, Valenzuela Camila, Gokerkucuk Elif Begum, Bontems François, Tachon Stéphane, Egger Keith T, Gazi Anastasia D, Sartori-Rupp Anna, Lesser Cammie F, Paul-Gilloteaux Perrine, Tinevez Jean-Yves, Vos Matthijn, Enninga Jost

The polyadenylase PAPI is required for virulence plasmid maintenance in pathogenic bacteria

多聚腺苷酸酶 PAPI 是致病菌毒力质粒维持所必需的。

Schubert, Katherine; Zhang, Jessica; Muscolo, Michele E; Braly, Micah; McCausland, Joshua W; Lam, Hanh N; Hug, Karen; Loven, Matthew; Ruiz Solis, Santiago; Estrada Escobar, Melissa; Moore, Henry; Terciano, Derfel; Fernandez Pacheco, Diana; Lowe, Todd M; Lesser, Cammie F; Jacobs-Wagner, Christine; Wang, Helen; Auerbuch, Victoria

Shigella OspF blocks rapid p38-dependent priming of the NAIP-NLRC4 inflammasome.

志贺氏菌 OspF 阻断 NAIP-NLRC4 炎症小体的 p38 依赖性快速启动

Turcotte Elizabeth A, Kim Kyungsub, Eislmayr Kevin D, Goers Lisa, Mitchell Patrick S, Lesser Cammie F, Vance Russell E

Living Engineered Bacterial Therapeutics: Emerging Affordable Precision Interventions

活体工程细菌疗法:新兴的、价格合理的精准干预手段

Srivastava, Rajkamal; Lesser, Cammie F

In situ deposition of nanobodies by an engineered commensal microbe promotes survival in a mouse model of enterohemorrhagic E. coli

利用工程化共生微生物原位沉积纳米抗体可提高肠出血性大肠杆菌小鼠模型的存活率

Srivastava, Rajkamal; González-Prieto, Coral; Lynch, Jason P; Muscolo, Michele E; Lin, Catherine Y; Brown, Markus A; Lemos, Luisa; Shrestha, Anishma; Osburne, Marcia S; Leong, John M; Lesser, Cammie F

Case Report and Clinical Reasoning: Fulminant Liver Failure and Invasive Aspergillosis Following Ocrelizumab Treatment in a 21 Year-Old Woman

病例报告及临床推理:一名21岁女性患者接受奥瑞珠单抗治疗后发生暴发性肝衰竭和侵袭性曲霉病

McEntire, Caleb R S; Lesser, Cammie F; Venna, Nagagopal

Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics

基于大肠杆菌 Nissle 1917 的治疗药物的新兴工程策略

Lynch, Jason P; Goers, Lisa; Lesser, Cammie F

Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads

III型分泌系统的合理性重新设计:旨在开发用于体内递送治疗有效载荷的非致病性大肠杆菌

González-Prieto, Coral; Lesser, Cammie F